CNO Financial compounds spreads, Medicare Supplement growth, and buybacks behind a defensible middle-market distribution moat, though valuation now demands strong execution.
Overview
CNO Financial Group is a specialized U.S. insurer and wealth-services platform focused on underserved middle-income pre-retirees and retirees. It earns revenue from insurance premiums, general-account investment income, and advisory and broker-dealer fees. Its competitive differentiation is a high-touch distribution model anchored by approximately 5,000 captive agents serving more than 220 communities, supported by simplified products and long customer relationships. **Operating momentum is improving:** Q1 2026 operating income rose 33% year over year to $101.3 million, or $1.05 per diluted share, beating the $0.94 consensus estimate, while management reaffirmed full-year 2026 operating EPS guidance of $4.25-$4.45. Medicare Supplement NAP increased 53%, producing agents rose 3% to 4,965, and advisory assets reached a record $5.1 billion. CNO is simultaneously exiting low-margin Optavise services and reinvesting in TechMod. The valuation is demanding at approximately 20.6x-21.0x trailing P/E versus an 11.5x-12.0x historical peer average, but is supported by 13.1% trailing operating ROE, 5% growth in ex-AOCI book value per share, buybacks, and sustained investment yields above 6%. Near-term catalysts include Medicare Supplement rate approvals, spread income, buybacks, and TechMod efficiencies.